Statistics

Total Visits

Views
Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program51

File Visits

Downloads
335.pdf31

Select a period of time:

Number of views in the range

Views
Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program35

Number of downloads in the range

Downloads
335.pdf29

Views

Views
December 202514
January 20262
February 20260
March 202610
April 20263
May 20263
June 20263
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • December 2025
    3
  • January 2026
    0
  • February 2026
    0
  • March 2026
    4
  • April 2026
    3
  • May 2026
    8
  • June 2026
    11
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States18
Argentina4
Canada2
Mexico2
Angola2
Brazil1
Ecuador1
United Kingdom1
Morocco1
Netherlands1
 

Top countries by downloads

Downloads
United States8
Argentina3
Netherlands3
United Kingdom2
Canada1
Morocco1
Brazil1
 

Top cities views

Views
San Jose2
Berazategui1
Cananea1
Caruaru1
Formosa1
García1
Groningen1
Guayaquil1
Jersey City1
La Plata1
 

Top cities by downloads

Downloads
Groningen2
La Plata1